JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Public Storage
PSA
$53B
| $675M | 0.08% |
2,233,776
-272,194
| -11% | -$80M |
2013 Q2
39 quarters
|
|
|
SGEN
252
DELISTED
Seagen Inc. Common Stock
SGEN
| $674M | 0.08% |
3,330,600
+57,811
| +2% | +$9.27M |
2013 Q2
39 quarters
|
|
253
Copart
CPRT
$25.2B
| $670M | 0.08% |
17,826,928
+345,782
| +2% | +$11.8M |
2015 Q1
32 quarters
|
|
254
Williams Companies
WMB
$86.3B
| $669M | 0.08% |
22,397,111
+2,071,480
| +10% | +$64M |
2013 Q2
39 quarters
|
|
255
Hubbell
HUBB
$25.1B
| $665M | 0.08% |
2,731,202
+148,953
| +6% | +$35.6M |
2015 Q4
29 quarters
|
|
256
Martin Marietta Materials
MLM
$34.3B
| $663M | 0.08% |
1,867,566
-293,136
| -14% | -$103M |
2013 Q2
39 quarters
|
|
257
Tractor Supply
TSCO
$16.2B
| $663M | 0.08% |
14,104,960
+406,200
| +3% | +$18.5M |
2013 Q2
39 quarters
|
|
258
SBA Communications
SBAC
$16.8B
| $662M | 0.08% |
2,537,428
+348,105
| +16% | +$95.8M |
2013 Q2
39 quarters
|
|
259
Marvell Technology
MRVL
$245B
| $661M | 0.08% |
15,262,863
+4,842,116
| +46% | +$204M |
2013 Q2
39 quarters
|
|
260
Kimberly-Clark
KMB
$31.4B
| $653M | 0.08% |
4,862,367
+307,221
| +7% | +$39.9M |
2013 Q2
39 quarters
|
|
261
T. Rowe Price
TROW
$22.3B
| $648M | 0.08% |
5,741,026
-1,568,204
| -21% | -$179M |
2013 Q2
39 quarters
|
|
262
EPAM Systems
EPAM
$5.59B
| $643M | 0.08% |
2,149,560
-377,354
| -15% | -$122M |
2013 Q3
38 quarters
|
|
263
Raymond James Financial
RJF
$30.4B
| $641M | 0.08% |
6,876,054
+1,448,047
| +27% | +$153M |
2013 Q2
39 quarters
|
|
264
Ross Stores
ROST
$73B
| $641M | 0.08% |
6,036,224
+1,048,817
| +21% | +$118M |
2013 Q2
39 quarters
|
|
265
Walt Disney
DIS
$176B
| $639M | 0.08% |
6,383,799
-2,450,607
| -28% | -$247M |
2013 Q2
39 quarters
|
|
266
Corning
GLW
$141B
| $639M | 0.08% |
18,103,774
+1,974,684
| +12% | +$68.7M |
2013 Q2
39 quarters
|
|
267
Diamondback Energy
FANG
$51.7B
| $637M | 0.08% |
4,710,552
-720,974
| -13% | -$100M |
2015 Q3
30 quarters
|
|
268
JPMorgan BetaBuilders US Small Cap Equity ETF
BBSC
$719M
| $635M | 0.08% |
11,704,459
+2,905,508
| +33% | +$162M |
2021 Q1
8 quarters
|
|
269
Sherwin-Williams
SHW
$77.6B
| $633M | 0.08% |
2,816,453
-35,272
| -1% | -$8.07M |
2013 Q2
39 quarters
|
|
270
Dow Inc
DOW
$20.2B
| $626M | 0.08% |
11,412,196
+9,531,751
| +507% | +$536M |
2019 Q2
15 quarters
|
|
271
Weyerhaeuser
WY
$13.3B
| $621M | 0.08% |
20,617,729
+401,373
| +2% | +$12.7M |
2013 Q2
39 quarters
|
|
272
Alnylam Pharmaceuticals
ALNY
$29.4B
| $620M | 0.08% |
3,094,734
-32,960
| -1% | -$6.93M |
2013 Q2
39 quarters
|
|
273
iShares MSCI EAFE Growth ETF
EFG
$15.5B
| $606M | 0.07% |
6,466,922
+2,747,559
| +74% | +$247M |
2013 Q2
39 quarters
|
|
|
HZNP
274
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $599M | 0.07% |
5,486,771
-5,762,118
| -51% | -$637M |
2014 Q4
33 quarters
|
|
|
275
CALL
Meta Platforms (Facebook)
META
$1.85T
| $597M | 0.07% |
2,816,000
-389,600
| -12% | -$66.4M |
2014 Q3
34 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.